Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Proceedings and Scrutinizer''s Report of the 40th Annual General Meeting {AGM) of Glenmark Pharmaceuticals Limited (''the Company'') held on September 28, 201828-09-2018
28-09-2018
U.S.$200,000,000 2.00 PER CENT. RESETTABLE ONWARD STARTING EQUITY-LINKED SECURITIES DUE 2022
With respect to the above subject, please find enclosed herewith launch announcement.28-09-2018
Intimation Of Proposed Cash Buyback In Respect Of Glenmark Pharmaceuticals Limited ('Company') Of Its U.S.$200 Million 2 Per Cent Resettable Onward Starting Equity Linked Securities Due 28 June 2022 ('FCC Bonds')
The Company had issued the FCC Bonds in 2016 which are currently listed on the Singapore Exchange Securities Trading Limited. Pursuant to our intimation letters dated 25 September 2018 and 28 September 2018, and the powers delegated to the Operations Committee by the Board of Directors of the Company, the Operations Committee in their meeting held today, approved that the Company is looking to buyback part of its FCC Bonds at repurchase price of...28-09-2018
Outcome of Board Meeting
Outcome of the Board Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to consider repurchase of Foreign Currency Debt28-09-2018
Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Glenmark Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here26-09-2018
Glenmark up as co considers buyback of FCCBs
Glenmark Pharma said its operations committee would consider opportunistic tenders or buybacks of any part of its Singapore listed foreign currency convertible bonds.26-09-2018
Result Of Postal Ballot (Including E-Voting) & Scrutinizer''s Report
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosures Requirements)Regulations, 2015 please find enclosed herewith results of the Postal Ballot (including E-voting) along with the Scrutinizer''s Report. You are requested to kindly take the same on record.25-09-2018
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (LODR) Regulations, 2015 To Consider Repurchase Of Foreign Currency Debt
GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/09/2018 ,inter alia, to consider and approve We hereby inform you that, pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015 as amended, a meeting of the Board of Directors of Glenmark Pharmaceuticals Limited ('Company') will be held on September 28, 2018, to consider opportunistic tenders or buybacks of any part of its...25-09-2018
Board Meeting on Sept 28, 2018
Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of Glenmark Pharmaceuticals Limited (Company) will be held on September 28, 2018, to consider opportunistic tenders or buybacks of any part of its Singapore listed foreign currency convertible bonds, being, its U.S.$200 million 2 per cent resettable onward starting equity linked securities due June 28, 2022 issued in 2016 (FCC Bonds) and / or, its U.S.$200...25-09-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sub: Glenmark Pharmaceuticals inducted into the Dow Jones Sustainability Indices (DJSI) Emerging Market 2018, one of the most prestigious global sustainability benchmarks19-09-2018